Rosella Silvestrini
Rosella Silvestrini
Meldola, Milano, Forlė
Verified email at istitutotumori.mi.it
TitleCited byYear
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
G Bonadonna, U Veronesi, C Brambilla, L Ferrari, A Luini, M Greco, ...
JNCI: Journal of the National Cancer Institute 82 (19), 1539-1545, 1990
7211990
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients
R Silvestrini, S Veneroni, MG Daidone, E Benini, P Boracchi, M Mezzetti, ...
JNCI: Journal of the National Cancer Institute 86 (7), 499-504, 1994
5681994
p53 as an independent prognostic marker in lymph node-negative breast cancer patients
R Silvestrini, E Benini, MG Daidone, S Veneroni, P Boracchi, V Cappelletti, ...
JNCI: Journal of the National Cancer Institute 85 (12), 965-970, 1993
3001993
‘Daunomycin’, a new antibiotic of the rhodomycin group
A Di Marco, M Gaetani, P Orezzi, BM Scarpinato, R Silvestrini, M Soldati, ...
Nature 201 (4920), 706, 1964
2961964
Cell kinetics as a prognostic marker in node‐negative breast cancer
R Silvestrini, MG Daidone, G Gasparini
Cancer 56 (8), 1982-1987, 1985
2291985
Cell proliferation and its relationship to clinical features and relapse in breast cancers
C Gentili, O Sanfilippo, R Silvestrini
Cancer 48 (4), 974-979, 1981
1931981
Interaction of some daunomycin derivatives with deoxyribonucleic acid and their biological activity
A Di Marco, F Zunino, R Silvestrini, C Gambarucci, RA Gambetta
Biochemical pharmacology 20 (6), 1323-1328, 1971
1661971
Labeling index as a prognostic marker in non-Hodgkin's lymphomas
A Costa, G Bonadonna, E Villa, P Valagussa, R Silvestrini
Journal of the National Cancer Institute 66 (1), 1-5, 1981
1621981
p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients.
R Silvestrini, E Benini, S Veneroni, MG Daidone, G Tomasic, ...
Journal of clinical oncology 14 (5), 1604-1610, 1996
1571996
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer
R Silvestrini, MG Daidone, G Di Fronzo, A Morabito, P Valagussa, ...
Breast cancer research and treatment 7 (3), 161-169, 1986
1461986
Relationship between proliferative activity and estrogen receptors in breast cancer
R Silvestrini, MG Daidone, GD Fronzo
Cancer 44 (2), 665-670, 1979
1441979
Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer.
G Bonadonna, P Valagussa, G Tancini, A Rossi, C Brambilla, M Zambetti, ...
NCI monographs: a publication of the National Cancer Institute, 45-49, 1986
1291986
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.
R Silvestrini, MG Daidone, A Luisi, P Boracchi, M Mezzetti, G Di Fronzo, ...
Journal of clinical oncology 13 (3), 697-704, 1995
1251995
Expression of p53, glutathione S-transferase-π, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer
R Silvestrini, S Veneroni, E Benini, MG Daidone, A Luisi, M Leutner, ...
Journal of the National Cancer Institute 89 (9), 639-645, 1997
1201997
Cell kinetics as a prognostic indicator in node-negative breast cancer
R Silvestrini, MG Daidone, P Valagussa, G Di Fronzo, G Mezzanotte, ...
European Journal of Cancer and Clinical Oncology 25 (8), 1165-1171, 1989
1141989
Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers
MG Daidone, R Silvestrini, A D'Errico, GD Fronzo, E Benini, AM Mancini, ...
International journal of cancer 48 (4), 529-532, 1991
1121991
Inhibiting effect of the new cytotoxic antibiotic daunomycin on nucleic acids and mitotic activity of HeLa cells
A Di Marco, R Silvestrini, S Di Marco, T Dasdia
The Journal of cell biology 27 (3), 545-550, 1965
1091965
Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine
O Sanfilippo, E Ronchi, C De Marco, G Di Fronzo, R Silvestrini
European Journal of Cancer and Clinical Oncology 27 (2), 155-158, 1991
1071991
Clinical studies of bcl-2 and treatment benefit in breast cancer patients.
MG Daidone, A Luisi, S Veneroni, E Benini, R Silvestrini
Endocrine-related cancer 6 (1), 61-68, 1999
1041999
Correlation of cell kinetic findings with morphology of non-Hodgkin's malignant lymphomas
R Silvestrini, R Piazza, A Riccardi, F Rilke
Journal of the National Cancer Institute 58 (3), 499-504, 1977
1011977
The system can't perform the operation now. Try again later.
Articles 1–20